FDA approves pancreatic cancer drug that extends patients lives The Washington Post

FDA approves pancreatic cancer drug that extends patients lives  The Washington Post

The Food and Drug Administration has approved a new pancreatic cancer drug, a pill that nearly doubled patients average survival times for one of the deadliest cancers when taken instead of chemother… [+3 chars]Read More

Leave a Reply

Your email address will not be published. Required fields are marked *